Technology made to speed up, increase
the success ratio and profitability of
Drug Design and Enzyme Engineering
Unique Monte Carlo based biomolecular modeling tools for all kind of early drug discovery and enzyme engineering programs.ACCESS TECHNOLOGIES
Forged in recognised academic groups, 75% of the company has a PhD with long and reputed experience working with clients.ACCESS TEAM
NUCLEIC ACIDSACCESS DIVISIONS
- Non-propietary Software
- Artificial Inteligence
- ED/MD Suite
Click on technologies to show their divisions
PELE Platform 1.6 is here
PELE Platform is a suite of packages that aims to find novel solutions to drug discovery problems in a matter of hours... And we just released a new version!
Bioactivity descriptors for uncharacterized chemical compounds
The SBNB group at IRB has been working on a deep neural networks methodology to infer bioactivity signatures of small molecule ligands with little experimental data available.